Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.5M Sell
133,818
-3,805
-3% -$1.3M 0.3% 51
2026
Q1
$48.4M Buy
137,623
+12,290
+10% +$4.38M 0.34% 38
2025
Q4
$41M Buy
125,333
+6,318
+5% +$2M 0.31% 48
2025
Q3
$33.6M Sell
119,015
-1,051
-0.9% -$305K 0.27% 53
2025
Q2
$33.5M Buy
120,066
+2,140
+2% +$606K 0.28% 50
2025
Q1
$36.7M Buy
117,926
+1,564
+1% +$462K 0.36% 39
2024
Q4
$30.3M Sell
116,362
-2,346
-2% -$696K 0.28% 46
2024
Q3
$38.2M Sell
118,708
-1,150
-1% -$376K 0.37% 37
2024
Q2
$37.4M Buy
119,858
+5,175
+5% +$1.52M 0.38% 36
2024
Q1
$32.6M Buy
114,683
+2,993
+3% +$876K 0.34% 45
2023
Q4
$32.2M Buy
111,690
+3,726
+3% +$1.02M 0.39% 37
2023
Q3
$29M Buy
107,964
+952
+0.9% +$238K 0.39% 35
2023
Q2
$23.8M Sell
107,012
-8,397
-7% -$1.95M 0.32% 50
2023
Q1
$27.9M Buy
115,409
+2,477
+2% +$608K 0.41% 39
2022
Q4
$29.7M Buy
112,932
+9,938
+10% +$2.66M 0.48% 30
2022
Q3
$23.2M Buy
102,994
+8,203
+9% +$1.99M 0.45% 32
2022
Q2
$23.1M Sell
94,791
-6,673
-7% -$1.64M 0.46% 32
2022
Q1
$24.5M Buy
101,464
+132
+0.1% +$30.3K 0.41% 41
2021
Q4
$22.8M Buy
101,332
+8,189
+9% +$1.73M 0.36% 50
2021
Q3
$19.8M Sell
93,143
-3,571
-4% -$822K 0.38% 46
2021
Q2
$23.6M Sell
96,714
-10,729
-10% -$2.64M 0.43% 38
2021
Q1
$26.7M Sell
107,443
-234
-0.2% -$55.8K 0.57% 31
2020
Q4
$24.8M Sell
107,677
-133
-0.1% -$30.7K 0.54% 33
2020
Q3
$27.4M Sell
107,810
-4,821
-4% -$1.19M 0.67% 25
2020
Q2
$26.6M Buy
+112,631
New +$25.7M 0.69% 21

Other funds holding AMGN

Xponance's AMGN Position: Q2 2026 in Review

Xponance reduced its Amgen (AMGN) stake by 2.8% in Q2 2026, selling an estimated $1.3M and leaving 133,818 shares worth $48.5M. The position accounts for 0.3% of the portfolio, ranked #51.

Xponance first reported a position in AMGN in Q2 2020 and has held it in 25 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Xponance held 133,818 shares of Amgen worth $48.5M as of Q2 2026.
  • Xponance sold 3,805 Amgen shares in Q2 2026, an estimated $1.3M.
  • Amgen made up 0.3% of Xponance's portfolio in Q2 2026, its #51 holding.
  • Xponance first reported a position in Amgen in Q2 2020 and has held it in 25 quarters since.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.